Clinical trial
Long-Term Follow-Up of Subjects Treated With NTLA 2002
NCT06262399 is registered in ClinicalTrials.gov with Intellia Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Long-Term Follow-Up of Subjects Treated With NTLA 2002
- Lead sponsor
- Intellia Therapeutics
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- April 12, 2024
- Completion date
- April 30, 2040
- Enrollment
- 100 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
hereditary angioedema